Alzheimer's Disease: Antibody Solanezumab has no Effect in the preclinical Stage

被引：0
|
作者：
Simon, Annika
机构：
来源：
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE | 2024年 / 92卷 / 07/08期
关键词：
D O I：
10.1055/a-2304-0921
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Humane monoklonale Antikorper zur Bindung verschiedener Amyloid-Formen gelten als gro ss e Hoffnung im Kampf gegen die Alzheimer-Demenz. So konnte der Antikorper Solanezumab in ersten Studien Amyloid-Monomere binden und eine gewisse neuroprotektive Funktion ubernehmen. Sperling et al. haben daher die Wirksamkeit von Solanezumab bei PatientInnen im praklinischen Stadium genauer betrachtet und
引用
收藏
页码：261 / 262
页数：2
相关论文
共 50 条
  • [41] Biomarkers for Preclinical Alzheimer's Disease
    Tan, Chen-Chen
    Yu, Jin-Tai
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (04) : 1051 - 1069
  • [42] Preclinical Alzheimer's Disease Therapeutics
    Rafii, Michael S.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 : S545 - S549
  • [43] Detection of preclinical Alzheimer's disease
    Skoog, I
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (07): : 502 - 503
  • [44] Biomarkers in preclinical Alzheimer's disease
    Chong, Mei Sian
    Lim, Wee Shiong
    Sahadevan, Suresh
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (07) : 600 - 607
  • [45] The first autopsy case of Alzheimer disease after treatment of anti-amyloid beta antibody (solanezumab)
    Higashi, Yasuto
    Murayama, Shigeo
    BRAIN PATHOLOGY, 2019, 29 : 72 - 72
  • [46] Preclinical Stage Alzheimer's Disease Detection Using Magnetic Resonance Image Scans
    Altay, Fatih
    Sanchez, Guillermo Ramon
    James, Yanli
    Faraone, Stephen, V
    Velipasalar, Senem
    Salekin, Asif
    THIRTY-FIFTH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, THIRTY-THIRD CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE AND THE ELEVENTH SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, 2021, 35 : 15088 - 15097
  • [47] Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease
    Stephan Müller
    Oliver Preische
    Hamid R. Sohrabi
    Susanne Gräber
    Mathias Jucker
    Janko Dietzsch
    John M. Ringman
    Ralph N. Martins
    Eric McDade
    Peter R. Schofield
    Bernardino Ghetti
    Martin Rossor
    Neill R. Graff-Radford
    Johannes Levin
    Douglas Galasko
    Kimberly A. Quaid
    Stephen Salloway
    Chengjie Xiong
    Tammie Benzinger
    Virginia Buckles
    Colin L. Masters
    Reisa Sperling
    Randall J. Bateman
    John C. Morris
    Christoph Laske
    Scientific Reports, 7
  • [48] Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease
    Mueller, Stephan
    Preische, Oliver
    Sohrabi, Hamid R.
    Graeber, Susanne
    Jucker, Mathias
    Dietzsch, Janko
    Ringman, John M.
    Martins, Ralph N.
    McDade, Eric
    Schofield, Peter R.
    Ghetti, Bernardino
    Rossor, Martin
    Graff-Radford, Neill R.
    Levin, Johannes
    Galasko, Douglas
    Quaid, Kimberly A.
    Salloway, Stephen
    Xiong, Chengjie
    Benzinger, Tammie
    Buckles, Virginia
    Masters, Colin L.
    Sperling, Reisa
    Bateman, Randall J.
    Morris, John C.
    Laske, Christoph
    SCIENTIFIC REPORTS, 2017, 7
  • [49] Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer's Disease
    Llamas-Rodriguez, Josue
    Oltmer, Jan
    Greve, Douglas N.
    Williams, Emily
    Slepneva, Natalya
    Wang, Ruopeng
    Champion, Samantha
    Lang-Orsini, Melanie
    Fischl, Bruce
    Frosch, Matthew P.
    van der Kouwe, Andre J. W.
    Augustinack, Jean C.
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 87 (03) : 1379 - 1399
  • [50] Peripheral olfactory system is impaired in preclinical stage of Alzheimer's Disease Mouse Model
    Yoo, SeungJun
    Lee, Ji-Hye
    Kim, So Yeun
    Cho, Bongki
    Ha, Sungji
    Yo, Seung-Woon
    Chang, Keun-A
    Suh, Yoo-Hun
    Moon, Cheil
    CHEMICAL SENSES, 2015, 40 (03) : 296 - 296
12345